PROCEPT BioRobotics Corporation PRCT
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 4.01% | 13.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.01% | 13.67% | |||
| Cost of Revenue | -5.36% | 19.99% | |||
| Gross Profit | 9.53% | 10.25% | |||
| SG&A Expenses | 4.08% | 7.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.70% | 7.82% | |||
| Operating Income | 9.62% | 7.10% | |||
| Income Before Tax | 0.72% | 15.51% | |||
| Income Tax Expenses | -161.70% | 318.60% | |||
| Earnings from Continuing Operations | 1.28% | 15.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.28% | 15.10% | |||
| EBIT | 9.62% | 7.10% | |||
| EBITDA | 12.24% | 8.32% | |||
| EPS Basic | 1.74% | 15.93% | |||
| Normalized Basic EPS | 10.83% | 7.28% | |||
| EPS Diluted | 1.74% | 15.93% | |||
| Normalized Diluted EPS | 10.83% | 7.28% | |||
| Average Basic Shares Outstanding | 0.45% | 0.98% | |||
| Average Diluted Shares Outstanding | 0.45% | 0.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||